ENTEROBIOTIX

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ENTEROBIOTIX was filed as Word mark on 12/02/2021 at the World Intellectual Property Organization.

Trademark Details Last update: July 28, 2023

Trademark form Word mark
File reference 1655920
Register number UK00003657556
Countries Australia Brazil Canada Switzerland Israel India Japan South Korea Mexico Malaysia New Zealand Singapore United States of America (USA)
Base trademark GB No. UK00003657556, December 3, 2021
Application date December 2, 2021
Expiration date December 2, 2031

Trademark owner

Phoenix House,
Phoenix Crescent,
GB

Trademark representatives

Gordon Lamb House, Jackson's Entry GB

goods and services

01 Chemicals, reagents and substances for medical research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; diagnostic preparations and reagents for scientific or research use; enzymes for scientific purposes; raw proteins; proteins for use in industry and in science; test kits for scientific or research use, comprised of buffer solutions, assays and reagents
05 Pharmaceutical, medical and veterinary preparations; pharmaceutical, medical and veterinary preparations in the field of microbiome modulating therapeutics; pharmaceutical, medical or veterinary preparations and substances; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of gastrointestinal disorders and diseases; drugs for medical purposes; biotechnological preparations for medical use; biological compounds for use in targeted pharmaceutical therapies; proteins with diagnostic and therapeutic uses for medical purposes; chemical and enzyme preparations for medical or veterinary purposes; reagents and substances for use in testing for medical and veterinary purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; intestinal microbiome pharmaceutical preparations; clinical medical reagents; diagnostic and testing preparations for clinical, medical and medical laboratory use; diagnostic reagents and assay components for clinical, medical and medical laboratory use; enzymes for medical purposes; yeast for intracellular production of recombinant proteins being biochemical preparations for medical purposes; yeast for pharmaceutical purposes; dietary supplements; food supplements; topical gels for medical and therapeutic use; intestinal microbiome medicinal preparations; pharmaceuticals or therapeutic preparations in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; diagnostic preparations for use in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; medical preparations for use in connection with intestinal microbiota transfer; chemical preparations and products, for use in medicine; diagnostic biomarkers for in vitro or in vivo testing for medical use
09 Computer software; software applications; mobile applications; cloud computing software; software algorithms; biometric software; databases; directories [electric or electronic]; artificial intelligence software for healthcare; health monitoring software; computer software for use in the fields of physiology, biology, genetics, genomics, metagenomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics and/or prebiotics; computer software for use in the fields of biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences and/or bacteria; computer software for scientific analysis of genetic sequences; interactive computer software; media streaming software; machine learning software for healthcare; machine learning software for analysis; downloadable computer software for remote monitoring and analysis; computer application software for streaming audio-visual media content via the internet; computer programs; encoded programs; measuring, detecting, monitoring and electronic controlling devices; wearable devices for taking biological measurements; instruments for analysing physical data; publications in electronic form; downloadable publications; electronic communications apparatus; scientific apparatus and instruments; teaching apparatus and instruments; apparatus and instruments for the recording, transmission or reproduction of data, sound or images; devices for analysing protein sequence used as laboratory apparatus; computers and computer hardware; encoded cards; smart cards; smart card readers; electronically encoded identity bracelets; parts and fittings for all the aforesaid goods
10 Medical devices; medical apparatus and instruments; medical analysis instruments; medical apparatus for introducing pharmaceutical preparations into the human body; medical instruments for use in connection with intestinal microbiota transfer; testing instruments for medical diagnostic purposes in relation to genetics, the human immune system and the human gut microbiome; medical diagnostic and testing apparatus in the field of microbiology; diagnostic and medical testing apparatus in the field of microbiome modulating therapeutics; medical diagnostic and testing apparatus in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; gloves for medical examinations; bags adapted for medical use; parts and fittings for all the aforesaid goods
42 Research and development services in the fields of medicine and health; research and development in the pharmaceutical and biotechnology fields; biological, scientific, clinical and medical research and development; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of compounds for use in targeted pharmaceutical therapies; medical and pharmacological research services; research relating to molecular sciences and biotechnology; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; scientific and medical research services in the field of microbiome modulating therapeutics; research and development of pharmaceutical preparations for the treatment of gastrointestinal disorders and diseases; research and development of biological drug delivery platforms; biochemical research and analysis; bacteriological research and analysis; scientific analysis in the field of intestinal microbiology; analysis of human excreta for medical research; microbiological testing; biological analysis; research, development, analysis and evaluation services in connection with biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences, bacteria, physiology, biology, genetics, genomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics, prebiotics and nutraceutical supplements; research and development services in connection with health care, wellness, physical well-being, mental well-being, exercise, weight planning, weight management, diet, nutrition and/or sleep; research, development, analysis and evaluation services in connection with microbiology, genetics, the human immune system and the human gut microbiome; research and development in connection with gastrointestinal health; DNA screening for scientific research purposes; testing of pharmaceuticals; testing, authentication and quality control; biotechnology and chemical testing; development of biochemical reagents; laboratory services; clinical research; clinical trials; conducting early evaluations in the field of new pharmaceuticals; research and development for use in clinical trials; providing information about the results of clinical trials for pharmaceutical products; technical measuring and testing services; structural and functional analysis of genomes; services for assessing the efficiency of medical and veterinary drugs; veterinary research and development services; product design and development; design services relating to the biotechnology industry; analysis of product development; pharmaceutical product evaluation; preparation of scientific reports in the field of biotechnology and/or gut health; scientific research and analysis; scientific research project management; scientific risk assessment; industrial analysis and research; analysis of product design; quality assessment; software design, development, programming and implementation; software engineering; development and design of mobile applications; computer programming; development of computer platforms; design, development and testing of computing methods, algorithms and software; software as a service [SAAS]; platform as a service [PaaS]; platform as a service featuring a computer software platform that enables access to technical studies and scientific and medical information; application service provider [ASP]; computer software maintenance; software and algorithm research; information technology services for the pharmaceutical and healthcare industries; writing of computer programs for biotechnological applications; development of virtual reality software; design and development of software for use in the fields of biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences and/or bacteria; database design; maintenance of database software; design and development of computer hardware; online data storage; cross-platform conversion of digital content into other forms of digital content; technical data analysis; data encryption services; updating of software; rental of software; data coding services being computer programming; process monitoring for quality assurance; hosting websites on the internet in the field of healthcare and wellness; DNA sequencing and sequencing of microbiomes in humans for research purposes; consultancy, information and advisory services relating to all of the aforesaid services
44 Medical and healthcare services; medical examinations; medical analysis services; health assessment surveys; health risk assessment surveys; medical health assessment services; medical analysis services relating to the treatment of persons; medical care services relating to patient treatment; analysis of human tissues for medical treatment; genetic testing for medical purposes; DNA screening for medical purposes; medical and health services relating to DNA, genetics and genetic testing; medical services relating to DNA sequencing and sequencing of microbiomes in humans; diagnostic testing and analysis services for medical purposes; analysis of human serum for medical treatment; analysis of human excreta for medical treatment; human serum donation services; donation of bodily fluids and human waste; donation of human excreta; behavioural analysis for medical purposes; psychological assessment services; providing online medical record services; preparation of reports relating to medical matters; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing health information via a website; medical services connected with intestinal microbiota transfer; consultancy, information and advisory services relating to all of the aforesaid services

Trademark history

Date Document number Area Entry
July 26, 2023 2023/30 Gaz CA Rejection
June 4, 2023 2023/24 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 1, 2023 2023/18 Gaz KR Rejection
March 16, 2023 2023/11 Gaz CH Rejection
February 9, 2023 2023/6 Gaz MX Rejection
February 2, 2023 2023/5 Gaz JP Rejection
January 18, 2023 2023/3 Gaz BR Rejection
December 8, 2022 2022/49 Gaz US Rejection
August 29, 2022 2022/38 Gaz IL Rejection
July 31, 2022 2022/32 Gaz NZ Rejection
July 1, 2022 2022/37 Gaz RAW: Limitation
June 28, 2022 2022/26 Gaz AU Rejection
May 9, 2022 2022/19 Gaz IN Rejection
December 2, 2021 2022/13 Gaz GB Registration

ID: 141655920